Locations:
SearchAdvertisement
Innovative treatments control cancer recurrence
Dose-finding trial adds to evidence of efficacy
Unique model is an excellent genetic animal model for study of lethal diseases
The technology could reduce complications by offering patients an alternative to open liver surgeries
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Four genomic clusters identified
May reveal small-volume metastatic cells not identified by standard radiotracers
Cael-101 + CyBorD dosing and outcomes
A major advance in prognosis for myelodysplastic syndromes that may improve outcomes
Cleveland Clinic’s radiation oncologists select highlights
Molecular markers could potentially predict major adverse side effects
Advertisement
Advertisement